Edward M. Kaye
2014 - Sarepta Therapeutics
In 2014, Edward M. Kaye earned a total compensation of $1.7M as President and Chief Executive Officer at Sarepta Therapeutics, a 36% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $131,676 |
|---|---|
| Option Awards | $1,155,231 |
| Salary | $399,017 |
| Other | $17,797 |
| Total | $1,703,721 |
Kaye received $1.2M in option awards, accounting for 68% of the total pay in 2014.
Kaye also received $131.7K in non-equity incentive plan, $399K in salary and $17.8K in other compensation.
Rankings
In 2014, Edward M. Kaye's compensation ranked 5,212th out of 13,032 executives tracked by ExecPay. In other words, Kaye earned more than 60.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,212 out of 13,032 | 60th |
Division Manufacturing | 1,862 out of 4,965 | 63rd |
Major group Chemicals And Allied Products | 622 out of 1,690 | 63rd |
Industry group Drugs | 474 out of 1,369 | 65th |
Industry Pharmaceutical Preparations | 375 out of 1,042 | 64th |
Source: SEC filing on April 27, 2017.
Kaye's colleagues
We found five more compensation records of executives who worked with Edward M. Kaye at Sarepta Therapeutics in 2014.
2014
Christopher Garabedian
Sarepta Therapeutics
Chief Executive Officer
2014
Arthur Krieg
Sarepta Therapeutics
Chief Scientific Officer
2014
Sandesh Mahatme
Sarepta Therapeutics
Chief Financial Officer
2014
David Howton
Sarepta Therapeutics
General Counsel
2014
Jayant Aphale
Sarepta Therapeutics